Kimberly Harding

TL;DR: There are numerous opportunities to significantly lessen the disparities in kidney transplantation for AAs through the adoption of new care and patient engagement models that include education, enhanced practice-level cultural sensitivity, and timely referral as well as increased research on the impact of the environment on genetic risk, and implementation of new transplantation-related policies.

TL;DR: Critical health information technology (IT) system deficiencies have left many low-income countries (LICs) the inability to support locally sustainable communicable and non-communicable disease prevention and screening initiatives and new therapeutic treatment plans that could save millions of lives.

TL;DR: The development and implementation of CKD-related evidence-based approaches, such as clinical and social determinant assessment tools for medical interventions, more widespread outreach programs, strategies to improve medication adherence, safe and effective pharmacological treatments to control or eliminate CKD, as well as the use of health information technology, and patient-engagement programs for improved CKD outcomes may help to positively impact these disparities among AAs.

TL;DR: The review addresses issues related to end-of-life support, the importance of Apolipoprotein-1 gene variants, and the advent of pharmacogenomics toward achieving precision care in ESRD care for AAs.